Recombinant IGF1R (Figitumumab Biosimilar) antibody
Quick Overview for Recombinant IGF1R (Figitumumab Biosimilar) antibody (ABIN7487920)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Figitumumab Biosimilar - Anti-IGF1R, CD221 mAb
-
Characteristics
- Antibody Type: IgG2-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG2
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IGF1R (Figitumumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
CP-751871
Figitumumab (CP-751, 871, CP), a human anti-IGF-IR monoclonal antibody (mAb), is proved to have antiproliferation and anti-tumorigenicity effects in cancer cells and xenografted mice, and it has been showed to be effective in combination with other cytotoxic agents to target many cancer types. -
CAS-No
- 943453-46-1
Target
-